Incidence rate and malignancy risk in new nodules in a lung cancer screening programme
Andrew Creamer(University College London), Allan Hackshaw(University College London), Priyam Verghese(University College London), Carolyn Horst(University College London), Sophie Tisi(University College London), Jennifer Dickson(University College London Hospitals NHS Foundation Trust), Chuen Ryan Khaw(University College London), Kylie Gyertson(University College London Hospitals NHS Foundation Trust), Laura Farrelly(University College London), Sam M. Janes(CRUK Lung Cancer Centre of Excellence), Helen Hall(University College London), Arjun Nair(University College London Hospitals NHS Foundation Trust), Ruth Prendecki(University College London), Anne-Marie Hacker(Cancer Research UK), John McCabe(University College London), Amyn Bhamani(Living Streets), Anand Devaraj(Harefield Hospital)
Cited by 2
Related Papers
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
|New England Journal of Medicine|2005|1.1k
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826
Infectious diseases in the aftermath of monsoon flooding in Pakistan
|Asian Pacific Journal of Tropical Biomedicine|2011|103